Narayan Prabhu
2021
In 2021, Narayan Prabhu earned a total compensation of $437.1K as Chief Financial Officer at REVIVA PHARMACEUTICALS HOLDINGS, a 865% increase compared to previous year.
Compensation breakdown
Option Awards | $162,134 |
---|---|
Salary | $275,000 |
Total | $437,134 |
Prabhu received $275K in salary, accounting for 63% of the total pay in 2021.
Prabhu also received $162.1K in option awards.
Rankings
In 2021, Narayan Prabhu's compensation ranked 11,004th out of 12,415 executives tracked by ExecPay. In other words, Prabhu earned more than 11.4% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 11,004 out of 12,415 | 11th |
Division Manufacturing | 4,855 out of 5,508 | 12th |
Major group Chemicals And Allied Products | 2,169 out of 2,378 | 9th |
Industry group Drugs | 1,930 out of 2,099 | 8th |
Industry Pharmaceutical Preparations | 1,429 out of 1,549 | 8th |
Source: SEC filing on October 11, 2022.
Prabhu's colleagues
We found two more compensation records of executives who worked with Narayan Prabhu at REVIVA PHARMACEUTICALS HOLDINGS in 2021.